✦ LIBER ✦

CHOP chemotherapy followed by Rituximab consolidation as first line treatment in patients with follicular lymphoma. Long-term follow-up of a phase 2 trial

✍ Scribed by Gerald Jäger; Franz Quehenberger; Werner Linkesch; Peter Neumeister

Book ID: 114794180
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 441 KB
Volume: 78
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.2007.00848.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rituximab (anti-CD20 monoclonal antibody

Rituximab (anti-CD20 monoclonal antibody) as consolidation of first-line CHOP chemotherapy in patients with follicular lymphoma: a phase II study

✍ Gerald Jäeger; Peter Neumeister; Ruth Brezinschek; Gerald Höfler; Franz Quehenbe 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

A phase II clinical trial of intensive c

A phase II clinical trial of intensive chemotherapy followed by consolidative stem cell transplant: long-term follow-up in newly diagnosed mantle cell lymphoma

✍ Andrew M. Evens; Jane N. Winter; Nanjiang Hou; Beverly P. Nelson; Alfred Rademak 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB

Long-term follow-up of patients with HIV

Long-term follow-up of patients with HIV-related diffuse large B-cell lymphomas treated in a phase II study with rituximab and CHOP

✍ Josep-Maria Ribera; Mireia Morgades; Eva González-Barca; Pilar Miralles; Armando 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

Rituximab as first-line and maintenance

Rituximab as first-line and maintenance therapy for patients with indolent non-Hodgkin's lymphoma: Interim follow-up of a multicenter phase II trial

✍ John D Hainsworth 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Combination therapy with fludarabine and

Combination therapy with fludarabine and rituximab followed by alemtuzumab in the first-line treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma : A phase 2 trial of the Minnie Pearl Cancer Research Network

✍ John D. Hainsworth; Elizabeth R. Vazquez; David R. Spigel; Eric Raefsky; James D 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

## Abstract ## BACKGROUND The purpose of the current study was to evaluate the efficacy and toxicity of the combination of fludarabine and rituximab, followed by alemtuzumab, as first‐line treatment for patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). ## METHO

Consolidation with alemtuzumab improves

Consolidation with alemtuzumab improves progression-free survival in patients with chronic lymphocytic leukaemia (CLL) in first remission – long-term follow-up of a randomized phase III trial of the German CLL Study Group (GCLLSG)

✍ Carmen D. Schweighofer; Matthias Ritgen; Barbara F. Eichhorst; Raymonde Busch; W 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB